(Q39446720)

12 September 2017

title

Vascular complications in diabetes: old messages, new thoughts (English)

1 reference

12 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725914%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Amelia K Fotheringham

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725914%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

19 July 2017

1 reference

12 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725914%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725914%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725914%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

2129-2138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725914%20AND%20SRC:MED&resulttype=core&format=json

Mechanisms of diabetic complications.

5 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

The emerging challenge in diabetes: the "metabolic memory".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Follow-up of blood-pressure lowering and glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Early atherosclerosis relates to urinary albumin excretion and cardiovascular risk factors in adolescents with type 1 diabetes: Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT): urinary screening and baseline biochemical and cardiovascular assessments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Renal and retinal effects of enalapril and losartan in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Glycemic Variability and Diabetes Complications: Does It Matter? Simply Put, There Are Better Glycemic Markers!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Glycemic variability: both sides of the story

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Metformin and the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

The Role of Mitochondria in Diabetic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Prevention of diabetic nephropathy in Ins2(+/)⁻(AkitaJ) mice by the mitochondria-targeted therapy MitoQ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Protection of mitochondria prevents high-fat diet-induced glomerulopathy and proximal tubular injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

The evolving understanding of the contribution of lipid metabolism to diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Challenging the dogma of mitochondrial reactive oxygen species overproduction in diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Oxidative stress as a major culprit in kidney disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Heritability of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Genetics of cardiovascular and renal complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

From single nucleotide polymorphism to transcriptional mechanism: a model for FRMD3 in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Diabetic nephropathy--emerging epigenetic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Noncoding RNAs in diabetes vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Regulation of Vascular Smooth Muscle Cell Dysfunction Under Diabetic Conditions by miR-504

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Does our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiome-gut-brain axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Coenzyme Q10 prevents GDP-sensitive mitochondrial uncoupling, glomerular hyperfiltration and proteinuria in kidneys from db/db mice as a model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4360-X

Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications

21 January 2018

1 reference

12 December 2020

Effects of intensive glucose lowering in type 2 diabetes

1 reference

12 December 2020

Cardiac autonomic dysfunction is associated with high-risk albumin-to-creatinine ratio in young adolescents with type 1 diabetes in AdDIT (adolescent type 1 diabetes cardio-renal interventional trial).

1 reference

12 December 2020

Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus

1 reference

12 December 2020

Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus

1 reference

12 December 2020

DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy

1 reference

12 December 2020

Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications

1 reference

12 December 2020

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

12 December 2020

Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes

1 reference

12 December 2020

DNA methylation profiling in cell models of diabetic nephropathy

1 reference

12 December 2020

10.1007/S00125-017-4360-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28725914%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference